Detalhe da pesquisa
1.
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial.
Respir Res
; 23(1): 202, 2022 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35945604